Learn about the latest strategies and solutions for orchestrating continuous conversations across all touchpoints. Discover how to maintain context, enable two-way compliant dialogue, automatically coordinate intelligent responses, and more.
Personalization and omnichannel marketing have dominated biopharma brand strategy for years, yet most brands have little to show for it.
For decades, the ‘shots on goal’ model has driven up R&D costs while failing to deliver results. Vertex Pharmaceuticals just proved there’s a better way.
Veeva Systems, which offers life sciences companies cloud-based commercial management software and business consulting services, is venturing into the consumer-facing side of things with the acquisition of Ostro.
Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences.
Ostro co-founder Ahmed Elsayyad explains how pharma marketers can earn attention by simplifying complexity, using engaging formats, and aligning content with audience needs in a crowded digital landscape.
Veeva is acquiring agentic AI company Ostro for $100 million to boost its AI capabilities for healthcare providers and patients.
.svg)